Indications and uses
To help support the repair & regeneration of connective tissue & cartilage.
To help support the repair & regeneration of connective tissue & cartilage.
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Anti-Interleukin-1 9 9X 200K, Ascorbic acid 8X 30K, Beta endorphin 8 9X 200K, bFibroblast Growth Factor 8 9X 200K, Cartilage 6X 200K, Collagen 8X 200K, Erythrocytes 8X 200K, Interleukin 3 3 12X 200K, Liver 6X 200K, Muscle 6X 200K, Tendon 8X 200K, Transforming Growth Factor-2 11X 200K
| Anti-Interleukin-1 | Anti-inflammation |
| Ascorbic acid | Anti-oxidant |
| Beta endorphin | Pain relief |
| bFibroblast Growth Factor | Regeneration |
| Cartilage | Regeneration |
| Collagen | Regeneration |
| Erythrocytes | Immune support |
| Interleukin 3 | Immune support |
| Liver | Regeneration |
| Muscle | Regeneration |
| Tendon | Regeneration |
| Transforming Growth Factor-2 | Immune support |
To help support the repair & regeneration of connective tissue & cartilage.
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
Keep this and all medicines out of reach of children.
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Alcohol and Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
ITEM: VPC0090
NDC 63776-100-14
Homeopathic remedy
Connectissue
• To help support the repair & regeneration of connective tissue & cartilage.
Oral spray
30ml 1 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Connectissue
30 mL
1 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0090
NDC: 63776-100-14
INDICATIONS:
To help support the repair & regeneration of connective tissue & cartilage
DIRECTIONS:
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-100-14 | 2024-01-30 | C162847 | 48780-1 | 1030e365-05e7-111a-e063-dadaa90a10e2 | Connectissue |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-100-14 | Connectissue | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 4 | |
| 63776-100-14 | Connectissue | 1 in 1 BOX | SPRAY | 1 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-100 | CONNECTISSUE (ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT, ASCORBIC ACID, METENKEFALIN, ERSOFERMIN, BOS TAURUS CARTILAGE, SUS SCROFA CARTILAGE, PORK COLLAGEN, BOS TAURUS RED BLOOD CELL, SUS SCROFA RED BLOOD CELL, INTERLEUKIN-3, INTERLEUKIN-3, BEEF LIVER, PORK LIVER, BEEF, PORK, BOS TAURUS TENDON, SUS SCROFA TENDON, CETERMIN) SPRAY [VIATREXX BIO INCORPORATED] | 4 | Legacy NDC, 2 package rows | 20221202_f5853cc7-9c1f-7b24-345f-c258b8965894.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE INGREDIENT | ML4QRZ1HCL | 1 | |
| Ascorbic Acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| Beef | ACTIVE INGREDIENT | 4PIB2155QP | 1 | |
| Beef Liver | ACTIVE INGREDIENT | W8N8R55022 | 1 | |
| Bos Taurus Cartilage | ACTIVE INGREDIENT | UE77B10IIY | 1 | |
| Bos Taurus Red Blood Cell | ACTIVE INGREDIENT | 5W4FLB0U2C | 1 | |
| Bos Taurus Tendon | ACTIVE INGREDIENT | 0470X06FYR | 1 | |
| Cetermin | ACTIVE INGREDIENT | 693Y43MXY4 | 1 | |
| Ersofermin | ACTIVE INGREDIENT | 1NWT5SW3NW | 1 | |
| Interleukin-3 | ACTIVE INGREDIENT | A802907MI4 | 1 | |
| Metenkefalin | ACTIVE INGREDIENT | 9JEZ9OD3AS | 1 | |
| Pork | ACTIVE INGREDIENT | O138UB266J | 1 | |
| Pork Collagen | ACTIVE INGREDIENT | I8442U2G7J | 1 | |
| Pork Liver | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| Sus Scrofa Cartilage | ACTIVE INGREDIENT | 73ECW5WG2F | 1 | |
| Sus Scrofa Red Blood Cell | ACTIVE INGREDIENT | 5X23IGF970 | 1 | |
| Sus Scrofa Tendon | ACTIVE INGREDIENT | R69Y34R8KU | 1 | |
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE MOIETY | ML4QRZ1HCL | 1 | |
| Ascorbic Acid | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| Beef | ACTIVE MOIETY | 4PIB2155QP | 1 | |
| Beef Liver | ACTIVE MOIETY | W8N8R55022 | 1 | |
| Bos Taurus Cartilage | ACTIVE MOIETY | UE77B10IIY | 1 | |
| Bos Taurus Red Blood Cell | ACTIVE MOIETY | 5W4FLB0U2C | 1 | |
| Bos Taurus Tendon | ACTIVE MOIETY | 0470X06FYR | 1 | |
| Cetermin | ACTIVE MOIETY | 693Y43MXY4 | 1 | |
| Ersofermin | ACTIVE MOIETY | 1NWT5SW3NW | 1 | |
| Interleukin-3 | ACTIVE MOIETY | A802907MI4 | 1 | |
| Metenkefalin | ACTIVE MOIETY | 9JEZ9OD3AS | 1 | |
| Pork | ACTIVE MOIETY | O138UB266J | 1 | |
| Pork Collagen | ACTIVE MOIETY | I8442U2G7J | 1 | |
| Pork Liver | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| Sus Scrofa Cartilage | ACTIVE MOIETY | 73ECW5WG2F | 1 | |
| Sus Scrofa Red Blood Cell | ACTIVE MOIETY | 5X23IGF970 | 1 | |
| Sus Scrofa Tendon | ACTIVE MOIETY | R69Y34R8KU | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-100 | 63776-100-14 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SUS SCROFA TENDON | R69Y34R8KU | ACTIB |
| CETERMIN | 693Y43MXY4 | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT | ML4QRZ1HCL | ACTIB |
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| METENKEFALIN | 9JEZ9OD3AS | ACTIB |
| ERSOFERMIN | 1NWT5SW3NW | ACTIB |
| BOS TAURUS CARTILAGE | UE77B10IIY | ACTIB |
| SUS SCROFA CARTILAGE | 73ECW5WG2F | ACTIB |
| PORK COLLAGEN | I8442U2G7J | ACTIB |
| BOS TAURUS RED BLOOD CELL | 5W4FLB0U2C | ACTIB |
| SUS SCROFA RED BLOOD CELL | 5X23IGF970 | ACTIB |
| INTERLEUKIN-3 | A802907MI4 | ACTIB |
| BEEF LIVER | W8N8R55022 | ACTIB |
| PORK LIVER | 6EC706HI7F | ACTIB |
| BEEF | 4PIB2155QP | ACTIB |
| PORK | O138UB266J | ACTIB |
| BOS TAURUS TENDON | 0470X06FYR | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eeb5e0c8-373e-b0d9-e053-2995a90a7b97 | f5853cc7-9c1f-7b24-345f-c258b8965894 | 2022-11-30 | Warnings | eeb5e0c8-373e-b0d9-e053-2995a90a7b97 f5853cc7-9c1f-7b24-345f-c258b8965894 |
Adverse event summaries are temporarily unavailable. Other product information remains available.